Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1695115

	registered interest
	date	11/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of (a) 3D mammography and (b) other new screening technologies to support the early diagnosis of breast cancer.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	17982
	answer	answer is ministerial correction date of answer 19/03/2024 answer text <p>The UK National Screening Committee (UK NSC) is aware of research into the use of three-dimensional (3D) mammography and the growing interest to use artificial intelligence (AI) in the National Health Service breast screening programme. Guidance has been published on GOV.UK on the use of Tomosynthesis 3D imaging in a clinical trial setting as part of the NHS breast screening programme.</p><p>The UK NSC had also worked with Health Technology Assessments to design an evaluation of existing AI in a prospective study to look at whether it could be used to read breast screening mammograms.</p><p>There are currently no plans to adopt these technologies, but evidence to inform a UK NSC decision on the use of 3D mammography and AI in the NHS breast screening programme will be reviewed by the Committee when available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/03/2024 14:57:39 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1695116

	registered interest
	date	11/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of (a) lowering the breast cancer screening age to 40 and (b) including a breast cancer risk assessment in the first appointment.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	17983
	answer	answer is ministerial correction date of answer 19/03/2024 answer text <p>The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 years old to 71 years old are invited for breast screening every three years. A trial, AgeX is looking at the impact of increasing or decreasing, or both, the screening age for the breast screening programme. When the results from this trial are available, the UK NSC will review the findings. The UK NSC plans to review the evidence for risk stratification in breast screening to tailor it more closely to an individual’s risk of cancer, rather than the current population-based approach.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/03/2024 15:37:13 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1695117

	registered interest
	date	11/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment her Department has made of the potential merits of introducing (a) a risk assessment and (b) a breast density assessment during a women's first breast cancer screening appointment.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	17984
	answer	answer is ministerial correction date of answer 19/03/2024 answer text <p>The UK National Screening Committee (UK NSC) plans to review the evidence for risk stratification in breast screening, to tailor it more closely to an individual’s risk of cancer, rather than the current population-based approach.</p><p> </p><p>In 2019, the UK NSC reviewed the benefit of additional screening with ultrasound after a negative mammography screening, for women with dense breasts. The Committee concluded that there was insufficient evidence to recommend additional ultrasound screening at that time.</p><p> </p><p>The Breast Screening Risk Adaptive Imaging for Density trial is looking into the use of supplementary imaging techniques for women within the standard breast screening programme, who are found to have radiographically dense breast tissue. The UK NSC will review this evidence when it becomes available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/03/2024 15:29:57 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1691759

	registered interest
	date	26/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the effectiveness of the national ambition for dementia diagnosis rates at ensuring that people under 65 receive (a) a timely dementia diagnosis and (b) appropriate post-diagnostic support.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	15763
	answer	answer is ministerial correction date of answer 04/03/2024 answer text <p>The dementia diagnosis rate is not calculated for patients aged under 65 years old. This is because the numbers of patients known to have dementia in the sample population age groups comprising the zero to 64-year-old age range, are not large enough for reliable estimates to be made. Nonetheless, NHS England is committed to delivering high quality care and support for every person with dementia at every age, and central to this is the provision of personalised care.</p><p>As part of the spending review settlement in 2021/22, £17 million was allocated to the National Health Service to address dementia waiting lists and to increase the number of diagnoses, which had been adversely impacted by the pandemic. NHS England will share reporting on the impact of this funding and examples of good practice with dementia clinical networks in March 2024.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 04/03/2024 17:58:42 answering member 4527 label Biography information for Helen Whately
	tabling member	4775 label Biography information for Elliot Colburn

1691369

	registered interest
	date	23/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the dementia diagnosis rate was for people aged under 65 who had developed symptoms on 23 February 2024; and if she will publish a monthly estimate of this rate within national primary care dementia data.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	15482
	answer	answer is ministerial correction date of answer 04/03/2024 answer text <p>The dementia diagnosis rate is not calculated for patients aged under 65 years old. This is because the numbers of patients known to have dementia in the sample population age groups comprising those aged between zero and 64 years old are not large enough for reliable estimates to be made.</p><p>The dementia diagnosis rate for patients aged 65 years old and over is calculated and published monthly via the Primary Care Dementia Data publication, which is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/primary-care-dementia-data" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/primary-care-dementia-data</a></p><p>This publication does include a monthly count of the number of patients aged 65 years old and under who do have a dementia diagnosis on their patient record; this is expressed as a raw count and as a percentage of registered patients aged between zero and 64 years old.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 04/03/2024 17:58:04 answering member 4527 label Biography information for Helen Whately
	tabling member	4775 label Biography information for Elliot Colburn

1691370

	registered interest
	date	23/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if her Department will take steps to require every Integrated Care Board to develop a young onset dementia pathway to (a) standardise and (b) improve dementia (i) care and (ii) support for people of working age.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	15483
	answer	answer is ministerial correction date of answer 04/03/2024 answer text <p>Provision of dementia health care services is the responsibility of local integrated care boards (ICBs). NHS England would expect ICBs to commission services based on local population needs, taking account of the National Institute for Health and Care Excellence guidelines.</p><p> </p><p>The Dementia Well Pathway includes diagnosing well, living/ supporting well and dying well, and highlights that services need to be integrated, commissioned, monitored, and aligned with NICE standards for each component of the pathway. It makes it clear that the needs, wishes and preferences of each individual, including those of working age, should be taken into account in planning and providing their care.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 04/03/2024 17:56:51 answering member 4527 label Biography information for Helen Whately
	tabling member	4775 label Biography information for Elliot Colburn

1689210

	registered interest
	date	16/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liver Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the report by the British Liver Trust entitled Liver Cancer – A Call to Action, published in October 2023, if she will make an assessment of the potential merits of implementing an optimal care pathway for liver cancer.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	14137
	answer	answer is ministerial correction date of answer 26/02/2024 answer text <p>The care of and treatment for patients with cancers, including liver cancer, is a priority for the Government. National Health Service cancer standards have been reformed with the support of clinicians to speed up diagnosis for patients, which means people will receive a diagnosis or have cancer ruled out within 28 days of urgent cancer referral from their general practice. NHS England’s Early Diagnosis of Cancer Programme is contributing to the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.</p><p>The Government is taking steps through NHS England to improve outcomes for cancer patients, including liver cancer. Diagnostic checks are a key part of cancer pathways and the 153 community diagnostic centres (CDCs) opened by the Government will give earlier diagnostic tests, benefitting millions of patients including those who are referred with suspected less survivable cancers. NHS systems have been asked to prioritise CDC capacity towards their most challenged cancer pathways, where this is clinically appropriate, and these centres have delivered over six million additional tests for all elective activity since July 2021.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/02/2024 10:28:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1686774

	registered interest
	date	01/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the availability of genomic testing.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	12685
	answer	answer is ministerial correction date of answer 09/02/2024 answer text <p>The National Genomic Test Directory defines which genomic tests must be delivered by the NHS Genomic Laboratory Hubs in England, as well as who is eligible for genomic testing. The directory currently covers testing for over 3,200 rare diseases and over 200 cancer clinical indications. NHS England regularly updates the directory, through a robust and evidence-based test evaluation process, to keep pace with scientific and technological advances, and to ensure that genomic testing is available for all patients for whom it would be of clinical benefit. Testing is available for all eligible patients across England.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 09/02/2024 10:40:07 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1686775

	registered interest
	date	01/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure future NHS genomic testing publications include data on access to different cancer tests based on an individual's (a) ethnicity, (b) socioeconomic status and (c) type of cancer test.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	12686
	answer	answer is ministerial correction date of answer 08/02/2024 answer text <p>National Health Service genomic testing activity data, collected from all seven NHS Genomic Laboratory Hubs, is available on the NHS England website. NHS England will continue to publish this data on a quarterly basis. The published data indicates the total volume of genomic testing activity completed per month, broken down into cancer and rare and inherited disease. The cancer data is further separated into nine different categories of cancer. NHS England is looking into separating this further if there are other specific categories of cancer test type which would be of interest. The published data does not currently include data broken down by ethnicity or socioeconomic status, but NHS England’s ambition is to improve and expand future publications of the data, which may include areas relating to health inequalities.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 08/02/2024 15:27:18 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1686776

	registered interest
	date	01/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the implications for her policies of variations in access to genetic and genomic testing for cancer through the NHS Genomics Medicine Service; and what steps her Department is taking to reduce these variations.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	12687
	answer	answer is ministerial correction date of answer 08/02/2024 answer text <p>The seven NHS Genomic Medicine Service Alliances raise awareness of genomics among healthcare professionals and support delivery of equitable access to genomic testing, clinical genetics, and genomic counselling services. NHS England has also established the NHS Genomics Ethics, Equity and Legal Advisory Group to ensure that the NHS Genomic Medicine Service (NHS GMS) provides equitable access to all patients. The group will identify and review appropriate datasets to inform health inequalities analysis of the NHS GMS, and identify actions to address inequalities.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 08/02/2024 15:44:36 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn